Overview

• Pineapple acquired 678,353 INJ in its first open‑market tranche, valued at about $8.9 million.
• The firm said it will stake the entire position onchain, targeting approximately 12.75% in annual rewards to create recurring revenue.
• Management signaled additional market purchases from the private placement as it seeks to be the largest INJ holder and staker.
• The company outlined plans to apply Injective’s infrastructure to mortgage data, servicing, settlement, and potential real‑world‑asset tokenization.
• The move follows staked‑INJ ETF filings by Rex Shares and Osprey Funds and coincides with Injective’s pre‑IPO perpetual launches and reported $1 billion in recent RWA‑futures volume.